EVER Pharma
Johannes Niederhauser's work experience includes serving as a Team Lead in Pharmaceutical Development at EVER Pharma (Group) since June 2022. Prior to this role, they worked as a Development Scientist at EVER Pharma (Group) from September 2018 to May 2022. Johannes also has experience as a Dozent at Paracelsus Medizinische Privatuniversität in March 2022 and as a Dozent at the same university in April 2021. Before that, they worked in project management at Biobank Graz from October 2017 to August 2018. Johannes Niederhauser started their career as a PHD Student at Graz University of Technology from January 2013 to December 2017. Johannes also gained experience as a Practicum Student at Sandoz in June and July 2009.
Johannes Niederhauser completed their Master of Science (MS) in Molekularbiologie from Karl-Franzens-Universität Graz, between 2005 and 2012. Johannes then pursued a Doktor (Ph.D.) degree in Biochemie und Molekularbiologie from Technische Universität Graz, from 2013 to 2017.
EVER Pharma
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics. From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety. Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules. We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.